EP4284926 - ACE2-RECEPTOR ECTODOMAIN FUSION MOLECULES AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 03.11.2023 Database last updated on 24.08.2024 | |
Former | The international publication has been made Status updated on 05.08.2022 | Most recent event Tooltip | 29.03.2024 | Change: Validation states | published on 01.05.2024 [2024/18] | 29.03.2024 | Change - extension states | published on 01.05.2024 [2024/18] | Applicant(s) | For all designated states National Research Council of Canada 1200 Montreal Road Ottawa, Ontario K1A 0R6 / CA | [2023/49] | Inventor(s) | 01 /
SULEA, Traian Kirkland, Québec H9J 3A2 / CA | 02 /
DUROCHER, Yves Montreal, Québec H4J 1M1 / CA | [2023/49] | Representative(s) | Fleuchaus & Gallo Partnerschaft mbB Steinerstraße 15/A 81369 München / DE | [2023/49] | Application number, filing date | 22745466.7 | 25.01.2022 | [2023/49] | WO2022IB50650 | Priority number, date | US202163141594P | 26.01.2021 Original published format: US 202163141594 P | [2023/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022162533 | Date: | 04.08.2022 | Language: | EN | [2022/31] | Type: | A1 Application with search report | No.: | EP4284926 | Date: | 06.12.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.08.2022 takes the place of the publication of the European patent application. | [2023/49] | Search report(s) | International search report - published on: | CA | 04.08.2022 | Classification | IPC: | C12N9/64, A61K38/48, A61P31/14, C07K19/00, C12N5/10, C12N9/96, C12N15/62, C12P21/02 | [2023/49] | CPC: |
C12N9/485 (EP,KR);
A61K38/4813 (KR);
A61P31/14 (EP,KR);
C12Y304/17023 (EP,KR);
A61K38/00 (EP);
C07K2319/30 (EP,KR);
C07K2319/70 (EP,KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/49] | Title | German: | ACE2-REZEPTOR-EKTODOMÄNENFUSIONSMOLEKÜLE UND VERWENDUNGEN DAVON | [2023/49] | English: | ACE2-RECEPTOR ECTODOMAIN FUSION MOLECULES AND USES THEREOF | [2023/49] | French: | MOLÉCULES DE FUSION D'ECTODOMAINES DU RÉCEPTEUR D'ECA-2 ET UTILISATIONS ASSOCIÉES | [2023/49] | Entry into regional phase | 28.08.2023 | National basic fee paid | 28.08.2023 | Search fee paid | 28.08.2023 | Designation fee(s) paid | 28.08.2023 | Examination fee paid | Examination procedure | 25.07.2023 | Amendment by applicant (claims and/or description) | 28.08.2023 | Examination requested [2023/49] | Fees paid | Renewal fee | 19.12.2023 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2018140456 (UNIV NORTHWESTERN [US]) [A] 1-21 * the whole document *; | [A]US10723785 (ECKELMAN BRENDAN P [US], et al) [A] 1-21* the whole document * |